3,038
Participants
Start Date
August 10, 2022
Primary Completion Date
August 23, 2027
Study Completion Date
August 23, 2027
HZ/su vaccine
No study intervention is administered in this extension study. Participants received the HZ/su vaccine administered in the ZOSTER-049 (NCT02723773), ZOSTER-006 (NCT01165177) and ZOSTER-022 (NCT01165229) primary studies. In order to assess the persistence of immune responses, participants provide blood samples at Day 1 and yearly from Month 12 until Month 48 in the current ZOSTER-101 study, according to their study group assignment. In case of a suspected HZ case diagnosis in any of the participants, clinical specimens from HZ lesions (3 replicate samples, collected on the same day, per participant) are collected to confirm the diagnosis of HZ by Polymerase Chain Reaction (PCR)
GSK Investigational Site, Taipei
GSK Investigational Site, Taoyuan
GSK Investigational Site, Westmead
GSK Investigational Site, Warrawong
GSK Investigational Site, Geelong
GSK Investigational Site, Barcelona
GSK Investigational Site, Taipei
GSK Investigational Site, Berlin
GSK Investigational Site, Tallinn
GSK Investigational Site, Pittsburgh
GSK Investigational Site, Genoa
GSK Investigational Site, Peralada( Girona)
GSK Investigational Site, Rosiers-d'Égletons
GSK Investigational Site, Milan
GSK Investigational Site, Turku
GSK Investigational Site, Elkridge
GSK Investigational Site, Hamburg
GSK Investigational Site, Hamburg
GSK Investigational Site, Marid
GSK Investigational Site, Madrid
GSK Investigational Site, Pori
GSK Investigational Site, Charlotte
GSK Investigational Site, Majadahonda( Madrid
GSK Investigational Site, Vic
GSK Investigational Site, Hickory
GSK Investigational Site, Tampere
GSK Investigational Site, Durango
GSK Investigational Site, Bristol
GSK Investigational Site, Magdeburg
GSK Investigational Site, Taichung
GSK Investigational Site, Essen
GSK Investigational Site, Essen
GSK Investigational Site, Valencia
GSK Investigational Site, Goch
GSK Investigational Site, Angers
GSK Investigational Site, Mûrs-Erigné
GSK Investigational Site, Tartu
GSK Investigational Site, Cologne
GSK Investigational Site, Laval
GSK Investigational Site, Mainz
GSK Investigational Site, Witten
GSK Investigational Site, Seinäjoki
GSK Investigational Site, Clermont-Ferrand
GSK Investigational Site, Flörsheim
GSK Investigational Site, Kokkola
GSK Investigational Site, Weinheim
GSK Investigational Site, San Antonio
GSK Investigational Site, Salt Lake City
GSK Investigational Site, Phoenix
GSK Investigational Site, Wangen
GSK Investigational Site, Oulu
GSK Investigational Site, Rednitzhembach
GSK Investigational Site, Wallerfing
GSK Investigational Site, Belo Horizonte
GSK Investigational Site, Curitiba
GSK Investigational Site, São Paulo
GSK Investigational Site, São Paulo
GSK Investigational Site, Vancouver
GSK Investigational Site, Victoria
GSK Investigational Site, Halifax
GSK Investigational Site, Truro
GSK Investigational Site, Toronto
GSK Investigational Site, Toronto
GSK Investigational Site, Mirabel
GSK Investigational Site, Québec
GSK Investigational Site, Québec
GSK Investigational Site, Sherbrooke
GSK Investigational Site, Brno
GSK Investigational Site, České Budějovice
GSK Investigational Site, Hradec Králové
GSK Investigational Site, Espoo
GSK Investigational Site, Helsinki
GSK Investigational Site, Helsinki
GSK Investigational Site, Järvenpää
GSK Investigational Site, Dresden
GSK Investigational Site, Freiberg
GSK Investigational Site, Shatin
GSK Investigational Site, Fukuoka
GSK Investigational Site, Fukuoka
GSK Investigational Site, Fukuoka
GSK Investigational Site, Fukuoka
GSK Investigational Site, Kanagawa
GSK Investigational Site, Tokyo
GSK Investigational Site, Ansan
GSK Investigational Site, Bucheon-si
GSK Investigational Site, Incheon
GSK Investigational Site, Kangwon-do
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Balenyà (Barcelona)
GSK Investigational Site, Barcelona
GSK Investigational Site, Centelles (Barcelona)
GSK Investigational Site, La Roca del Vallès
GSK Investigational Site, Borås
GSK Investigational Site, Gothenburg
GSK Investigational Site, Karlskrona
GSK Investigational Site, Stockholm
GSK Investigational Site, Linköping
GSK Investigational Site, Malmo
GSK Investigational Site, Örebro
GSK Investigational Site, Upplands Vasby
GSK Investigational Site, Uppsala
GSK Investigational Site, Buckshaw Village, Chorley
GSK Investigational Site, Bradford-on-Avon
GSK Investigational Site, Belfast
GSK Investigational Site, Broughshane
GSK Investigational Site, Liverpool
Lead Sponsor
GlaxoSmithKline
INDUSTRY